Product Terms and Conditions Rules - Designated Contract Markets : 61198
Organization: KEX
Description: Kalshi restructures its FDA decision contract into a binary Yes/No market, refines approval-based payout rules (including Refuse-to-File), adds a void-at-last-fair-price mechanic for PDUFA extensions, and updates related definitions and examples
Products Affected:
Official Receipt Date: 2026-06-11 00:00:00
Status: Certified
Date: 2026-06-26 00:00:00
Remarks:
| Associated Documents |
|---|
| REQUEST FOR CONFIDENTIAL TREATMENT - DETAILED WRITTEN JUSTIFICATION |
| Will the FDA's decision on <drug> in <time period> be <outcome>? |
| Redline |